Literature DB >> 20738298

Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemia.

Vesna Najfeld, Joseph Tripodi, Angela Scalise, Lewis R Silverman, Richard T Silver, Steven Fruchtman, Ronald Hoffman.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20738298     DOI： 10.1111/j.1365-2141.2010.08355.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53.

Authors:  Bridget K Marcellino; Ronald Hoffman; Joseph Tripodi; Min Lu; Heidi Kosiorek; John Mascarenhas; Raajit K Rampal; Amylou Dueck; Vesna Najfeld
Journal:  Blood Adv       Date:  2018-12-26

2.  Jumping translocations, a novel finding in chronic lymphocytic leukaemia.

Authors:  Cecelia R Miller; Deborah Stephens; Amy S Ruppert; Frederick Racke; Andrew McFaddin; Heather Breidenbach; Huey-Jen Lin; Kathy Waller; Tammy Bannerman; Jeffrey A Jones; Jennifer A Woyach; Leslie A Andritsos; Kami Maddocks; Weiqiang Zhao; Gerard Lozanski; Joseph M Flynn; Michael Grever; John C Byrd; Nyla A Heerema
Journal:  Br J Haematol       Date:  2015-04-19       Impact factor: 6.998

3.  Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival.

Authors:  David Sanford; Courtney D DiNardo; Guilin Tang; Jorge E Cortes; Srdan Verstovsek; Elias Jabbour; Farhad Ravandi; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06-06

4.  Jumping translocations in myelodysplastic syndromes.

Authors:  Cecilia C S Yeung; H Joachim Deeg; Colin Pritchard; David Wu; Min Fang
Journal:  Cancer Genet       Date:  2016-08-08

5.  Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms.

Authors:  Selena Zhou; Douglas Tremblay; Ronald Hoffman; Marina Kremyanskaya; Vesna Najfeld; Lihua Li; Erin Moshier; John Mascarenhas
Journal:  Acta Haematol       Date:  2020-03-11       Impact factor: 2.195

6.  [Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome].

Authors:  Wei Wang; Zhimei Chen; Mengxia Yu; Huanping Wang; Jiyu Lou; Huan Xu; Chao Hu; Qitian Mu; Hongyan Tong; Juying Wei; Xinping Zhou; Jie Jin
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2015-10

7.  Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications.

Authors:  Sherry Bhalla; David T Melnekoff; Adolfo Aleman; Violetta Leshchenko; Paula Restrepo; Jonathan Keats; Kenan Onel; Jeffrey R Sawyer; Deepu Madduri; Joshua Richter; Shambavi Richard; Ajai Chari; Hearn Jay Cho; Joel T Dudley; Sundar Jagannath; Alessandro Laganà; Samir Parekh
Journal:  Sci Adv       Date:  2021-11-17       Impact factor: 14.136

8.  Jumping Translocations of 1q in Myelodysplastic Syndrome and Acute Myeloid Leukemia: Report of Three Cases and Review of Literature.

Authors:  T Couture; K Amato; A DiAdamo; P Li
Journal:  Case Rep Genet       Date:  2018-09-09

9.  Jumping translocations of chromosome 1q occurring by a multi-stage process in an acute myeloid leukemia progressed from myelodysplastic syndrome with a TET2 mutation.

Authors:  Ina Lee; Mary A Gudipati; Elizabeth Waters; Vu H Duong; Maria R Baer; Ying Zou
Journal:  Mol Cytogenet       Date:  2019-11-19       Impact factor: 2.009
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.